Keeping Current

Keeping Current

Opportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?

Informações:

Añadir a la estante
Escucha
muestra
Escucha

Sinopsis

Dr Curigliano and Dr Loi discuss the latest clinical data regarding the use of PARP inhibitors in early high-risk breast cancer. Credit available for this activity expires: 7/29/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955496?src=mkm_podcast_addon_955496

Show more